All of Us (initiative)

This article's "Core Values" and "What Data is Collected" sections contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (April 2023) (Learn how and when to remove this message)

All of Us

Headquarters	Bethesda, Maryland, United States
Parent organization	National Institutes of Health (NIH)
Website	allofus.nih.gov

The All of Us Research Program (previously known as the Precision Medicine Initiative Cohort Program^[1]) is a research program created in 2015 during the tenure of Barack Obama with $130 million^[2] in funding that aims to make advances in tailoring medical care to the individual.^[3] The mission of All of Us is to accelerate health and medical breakthroughs, enabling individualized prevention, treatment and care.

The project aims to collect genetic and health data from one million volunteers.^[4] The initiative was announced during the 2015 State of the Union Address,^[5] and is run by the National Institutes of Health (NIH). The program is bilingual, with information and materials available in Spanish and English.

Eligible adults (18 and over) can enroll with the program. People who are not eligible are those in prison or people who cannot consent on their own^[6] According to a sample consent form released in June 2018, participation in All of Us is voluntary and does not affect a participant's medical care. The form explains that if a participant quits the program, their samples will be destroyed.^[7] Children may also be able to enroll in the program.^[8]

By January 2018 an initial pilot project had enrolled about 10,000 people and 2022 was targeted for one million people.^[9] As of May 2019, enrollment numbers at the one-year launch anniversary are 187,000+ participants. More than 132,000 have already given biosamples.^[10]

The NIH reported in May 2018 that they were pleased with the high enrollment by underrepresented groups including communities of color and individuals with lower incomes. Up to three-quarters of beta phase participants came from those communities.^[11][8]

All of Us has more than 100 partners and champions working together to implement and support the mission and goals of the research program.^[12] Google life sciences startup Verily Life Sciences, a Google "moonshot" with a goal of "transform[ing] the way we detect, prevent, and manage disease"^[13][7] is one partner.

The initiative was identified by a 2019 review as involving the public in every stage of the research.^[14]

The All of Us Research Program budget has increased every year since it launched: FY2016 - $130 million; FY2017 - $230 million; and FY2018 - $290 million.^[15][16]

Professor Kenneth Weiss from Pennsylvania State University, in a skeptical review of this project in 2017, suggested that the funding could be better spent elsewhere.^[17]

The project suffered backlash in 2024 to their use of umap plotting to depict ancestry, rather than principal components analysis.^[18]

The research program was launched for national enrollment on May 6, 2018.^[11] In the summer of 2019, one year after its official launch, All of Us had enrolled 230,000 participants, which represents almost one quarter of the program's goal of 1,000,000 individuals. Approximately 80% of those people are from groups that have been traditionally underrepresented in biomedical research. One of All of US's main goals is to include many people from diverse ancestries.^[19] By June 2020, enrollment reached approximately 350,000 individuals.^[20]

On May 27, 2020, the All of Us research program announced the launch of their research platform, the All of Us Researcher Workbench, for beta testing. Select data collected by the initiative, including electronic health records and survey responses from the first 225,000 program participants, will be available to approved researchers through the workbench.^[20] Researchers may apply for access to the data if they have an NIH eRA Commons account (for identity verification) and are affiliated with an institution that has signed a data use agreement with All of Us.^[21]

In June 2020, the NIH announced that research materials collected as part of the All of Us initiative will be used to address the COVID-19 pandemic. Blood samples collected from recent volunteers will be tested for SARS-CoV-2 antibodies in order to track prior infections within the US population.^[22] Electronic health records shared by All of Us participants will also be evaluated for potential patterns associated with SARS-CoV-2 infection. All of Us also added monthly participant surveys with questions about the physical, mental, and socioeconomic impacts of the COVID-19 pandemic.^[23]

The founding program director was Eric Dishman, who stepped down to become the Chief Innovation Officer.^[24] In 2019, Joshua Denny was selected to be the second director.^[25] In October 2016, the project was renamed "All of Us".^[26][27][28]

• 100,000 Genomes Project (UK)
• 21st Century Cures Act
• Baseline Study
• Precision medicine
• precisionFDA

• Join All of Us homepage to join the All of Us research program
• All of Us homepage at the National Institutes of Health
• NIH Innovation account on USAspending.gov